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Purpose: The primate retina contains a specialized, cone-rich macula, which mediates high acuity and color vision. The
spatial resolution provided by the neural retina at the macula is optimized by stereotyped retinal blood vessel and ganglion
cell axon patterning, which radiate away from the macula and reduce shadowing of macular photoreceptors. However,
the genes that mediate these specializations, and the reasons for the vulnerability of the macula to degenerative disease,
remain obscure. The aim of this study was to identify novel genes that may influence retinal vascular patterning and
definition of the foveal avascular area.
Methods: We used RNA from human fetal retinas at 19–20 weeks of gestation (WG; n=4) to measure differential gene
expression in the macula, a region nasal to disc (nasal) and in the surrounding retina (surround) by hybridization to 12
GeneChip® microarrays (HG-U133 Plus 2.0). The raw data was subjected to quality control assessment and preprocessing,
using GC-RMA. We then used ANOVA analysis (Partek® Genomic Suite™ 6.3) and clustering (DAVID website) to
identify the most highly represented genes clustered according to “biological process.” The neural retina is fully
differentiated at the macula at 19–20 WG, while neuronal progenitor cells are present throughout the rest of the retina.
We therefore excluded genes associated with the cell cycle, and markers of differentiated neurons, from further analyses.
Significantly regulated genes (p<0.01) were then identified in a second round of clustering according to molecular/reaction
(KEGG) pathway. Genes of interest were verified by quantitative PCR (QRT–PCR), and 2 genes were localized by in situ
hybridization.
Results: We generated two lists of differentially regulated genes: “macula versus surround” and “macula versus nasal.”
KEGG pathway clustering of the filtered gene lists identified 25 axon guidance-related genes that are differentially
regulated in the macula. Furthermore, we found significant upregulation of three anti-angiogenic factors in the macula:
pigment epithelium derived factor (PEDF), natriuretic peptide precurusor B (NPPB), and collagen type IVα2. Differential
expression of several members of the ephrin and semaphorin axon guidance gene families, PEDF, and NPPB was verified
by QRT–PCR. Localization of PEDF and Eph-A6 mRNAs in sections of macaque retina shows expression of both genes
concentrates in the ganglion cell layer (GCL) at the developing fovea, consistent with an involvement in definition of the
foveal avascular area.
Conclusions: Because the axons of macular ganglion cells exit the retina from around 8 WG, we suggest that the axon
guidance genes highly expressed at the macula at 19–20 WG are also involved in vascular patterning, along with PEDF and
NPPB. Localization of both PEDF and Eph-A6 mRNAs to the GCL of the developing fovea supports this idea. It is possible
that specialization of the macular vessels, including definition of the foveal avascular area, is mediated by processes that
piggyback on axon guidance mechanisms in effect earlier in development. These findings may be useful to understand
the vulnerability of the macula to degeneration and to develop new therapeutic strategies to inhibit neovascularization.
A unique adaptation of the central retina in monkeys and
humans is the distinctive macula, at the center of which is the
highly specialized fovea centralis (fovea; Figure 1). Within
the macula the density of all neural elements is elevated and
there are no large retinal vessels. At the fovea there are no
rods, but there is a peak spatial density of cone photoreceptors,
and a prevalence of “midget” circuitry that mediates high
acuity and color vision [1]. Several retinal diseases
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specifically affect the macula, including Best's disease,
macular telangiectasia, Stargardt's macular dystrophy, and
age-related macular degeneration (AMD). It is not known why
the macula is the focus of these disorders. AMD is the most
common cause of untreatable blindness, resulting from
degeneration of macular photoreceptors, with or without
neovascularization [2]. While recent gene association studies
attribute high risk for AMD to a relatively small number of
SNPs [3-6], why the disease specifically affects the macula
remains poorly understood. Because of the vulnerability of the
macula, and the high impact consequences of macular disease,
there has been considerable interest in identifying genes
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differentially expressed in the macula and foveal region
[7-10]. To our knowledge, however, no studies have
investigated differential gene expression in the macula during
development, that is, during the period when genes that are
preferentially associated with determination of macular
characteristics are most likely to be expressed.
In all species examined, the fovea is found within an area
devoid of retinal vessels - the foveal avascular area (Figure 1)
[11]. In humans retinal vessels enter the developing human
retina in the 14th week of fetal life (14 weeks of gestation;
WG) and grow slowly toward the developing macula,
compared with the rest of the retina [12]. In normal
development, the foveal region is never vascularized [13], and
absence of a foveal avascular region is associated with foveal
hypoplasia [14,15]. During fetal life, the macula is the most
developmentally advanced region of the neural retina, and the
principal angiogenic factor, vascular endothelial growth
factor (VEGF), is highly expressed by ganglion cells in the
macula [16]. Despite this, blood vessels growing into the
macular region proceed slowly [12], have lower rates of
proliferation [17], and appear to face a molecular barrier that
prevents formation of vessels at the incipient fovea [18,19].
Developmental studies of macaque and marmoset retinas also
indicate that the fovea forms only after the foveal avascular
area has been defined [18,20].
The photoreceptor layer is normally avascular throughout
life, and neovascularization of the outer retina is associated
with vision loss, as in exudative AMD. It is thought that a
critical balance between the pro-angiogenic factor VEGF and
the anti-angiogenic pigment epithelial derived factor
(PEDF) is essential for preserving the avascular environment
of the outer retina [21]. Both of these factors are expressed by
the retinal pigmented epithelium. However, to date there have
been no reports of differential expression of PEDF or other
anti-angiogenic factors that may be involved in definition of
the foveal avascular area, even though data from several gene
expression studies of adult retina have been reported [9,10].
Furthermore, because guidance factors commonly define “no-
go” zones for axons, and members of the ephrin, netrin, slit,
and semaphorin families have roles in both axon and vascular
guidance [22], we hypothesized that a gradient of guidance
molecules centered on the incipient fovea might also
participate in definition of the foveal avascular area. Our aim,
therefore, was to determine if genes associated with anti-
angiogenic regulation as well as axon and vascular guidance
are differentially expressed in the macula during
development.
              METHODS
Human retinas: Human retinas (n=18) were obtained at
surgery to terminate pregnancy from fetuses between 17 and
20 WG, with informed maternal consent and ethical approval
from Human Ethics Committees of The University of Sydney
and The Australian National University. Gestational age was
determined by ultrasound before surgery and confirmed by
postmortem measurements of foot length.
RNA extraction: For hybridization to microarrays (4 retinas),
eyes were removed and stored in separate solution-free
containers, on ice, prior to dissection. RNA was extracted
from these retinas 90-120 min post mortem. For QRT-PCR,
whole eyes were placed in TRIzol Reagent (Invitrogen,
Carlsbad, CA) and frozen at -80 °C for subsequent RNA
extraction, up to one month post mortem. The anterior
segment and vitreous were dissected away, and the eye cup
was flattened by making radial cuts through the sclera and
retina. A 5 mm trephine was used to take two biopsies of each
retina: one from the posterior pole (“macula” sample), and a
second from the corresponding region immediately nasal to
Figure 1. Adult and fetal human retinas. A: Image showing the fundus of an adult human eye with the optic disc (OD), the macula (broken
circle) and the location of the fovea centralis (asterisk) indicated. The large retinal vessels extend from the optic disc into the supero-temporal
and infero-temporal retina (white arrows), but do not grow directly toward the macula. Only fine caliber vessels are present in the macula. B:
High power micrograph showing microvessels (black arrows) surrounding the fovea centralis in a retinal flatmount. The fovea is a shallow
depression, <1 mm in diameter, in the surface of the retina, located at the center of the macula, and centered on an avascular area 500–700
μm in diameter. Absence of capillaries at the fovea ensures that the highest quality image possible reaches the photoreceptors. C: A diagram
of a flatmounted human fetal retina at 19 WG showing the vascularized region of the retina at this stage in gray, and the location of the fovea
(asterisk). The two circles indicate the approximate size and location of biopsies taken from nasal and temporal retina, and used for RNA
extraction for this study. RNA was also extracted from the remainder of the retina (surround).
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the optic disc (“nasal” sample). The remaining retina was used
as a third sample region (“surround” sample). The biopsied
regions are illustrated in Figure 1C. Each of the three retinal
biopsies (macula, nasal, and surround) was homogenized then
combined with TRIzol® Reagent (Invitrogen, Carlsbad, CA)
and chloroform to separate the RNA from other cell
components. The RNA was then purified and isolated using
RNAqueous®-Micro RNA isolation kit (Ambion, Inc., Austin,
TX). RNA concentration was determined using a NanoDrop®
ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, DE). The RNA Integrity Number (RIN –
determined by the Agilent Bioanalyzer 2100 eukaryotic total
RNA Nano assay, Agilent Technologies, Inc., Santa Clara,
CA) was used as a measure of the quality of the RNA [23]. In
some cases where genomic DNA contamination was a
concern, the RNA was DNase treated [24]. This treatment did
not affect the RIN.
Microarray: Three sample regions (macula, nasal, and
surround) from each of four retinas, three at 19 WG and one
at 20 WG were used for microarray analysis. Double-stranded
cDNA was generated from each of the twelve total-RNA
samples and transcribed to obtain biotin-labeled cRNA. The
target cRNAs were fragmented, combined with hybridization
and spike controls, then hybridized to the twelve HG-U133
Plus 2.0 GeneChip® microarrays (Affymetrix, Inc., Santa
Clara, CA) for 16 h. Because of the limited availability of
suitable donor retinas, six cDNA samples (from two retinas)
were hybridized to microarrays on two separate occasions,
that is, the hybridizations were performed in two batches.
Following hybridization, the arrays were washed and stained
with streptavidin phycoerythrin conjugate using an automated
GeneChip® Fluidics Station 450, and then scanned with a
GeneChip® Scanner 3000 using a 570 nm excitation
wavelength laser. Target sample preparation and microarray
hybridization and scanning were performed at the
Biomolecular Resource Facility, John Curtin School of
Medical Research, The Australian National University
(Canberra, Australia).
To allow correct alignment of the software analysis grid,
a control oligo (B2 oligo) was hybridized and used to indicate
the boundaries of the probe area. Other quality control metrics
used include average background and noise (Raw Q) of the
measured probe cell intensities, ratio of expression of the 3′
probe set to 5′ probe set of the housekeeping control gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and
the percentage of all probe sets on the array detected as
present. Poly(A) sense RNA labeling controls and antisense
biotinylated cRNA hybridization controls (together with the
B2 oligo) were also spiked into the total RNA and biotinylated
cRNA cocktails, respectively, at known concentrations before
array hybridization (Affymetrix, Inc., GeneChip Expression
Analysis technical manual; 2003). The poly(A) RNA controls
were generated from four cloned B. subtilis genes (lys, phe,
thr, and dap), and the hybridization controls transcribed from
three E. coli genes (bioB, bioC, and bioD) and one P1
bacteriophage recombinase gene (cre).
The perfect match (PM) and mismatch (MM) probe
intensities were used to generate a detection call (present,
marginal, or absent) for each probe set, to assess the reliability
of detection of a transcript. Detection calls were generated by
the microarray suite version 5 (MAS5) algorithm. Microarray
quality controls were assessed using GeneChip® Operating
Software (Affymetrix).
Data analysis - preprocessing: Affymetrix CEL files were
imported into Partek® Genomics Suite™ 6.3 (Partek Inc., St.
Louis, MO) using the default Partek normalization
parameters. Probe-level data was pre-processed, including
background correction, normalization, and summarization
[25], using robust multi-array average (RMA) analysis
adjusted for probe sequence and GC content (GC-RMA). GC-
RMA adjusts for background noise on each array using only
the PM probe intensities; subsequent data normalization was
performed across all arrays using quantile normalization [26,
27]. The background-adjusted, normalized PM values were
then compiled, or summarized, within each probe set, using
the median polish technique, to generate a single measure of
expression [27]. These expression measures were then log
transformed, base 2.
Data analysis - differential expression analysis: Differential
expression analysis was performed using a two-way ANOVA
in which the variables were sample region (macula, nasal, and
surround) and hybridization batch. No significant batch effect
was evident in the data. Data from the four macula arrays were
grouped and compared (using a linear contrast) with either the
four nasal or surround arrays as baselines. The lists of
differentially expressed genes from the macula versus
surround and macula versus nasal data were clustered
according to functional roles or biological process as specified
by the Gene Ontology Consortium [28]. This was achieved
using the functional annotation tool on the Database for
Annotation, Visualization, and Integrated Discovery
(DAVID) website [29] with an Expression Analysis
Systematic Explorer (EASE) score threshold (a modified
Fisher Exact p-value) of 0.1.
The retina differentiates in a gradient which progresses
from the macula to the periphery. At 19–20 WG (the ages of
our samples), the majority of cells in the macula have exited
the cell cycle and differentiated as neurons, while the majority
of cells in non-macular locations are still proliferating [30].
Because of these significant differences in cell function
between macular and non-macular locations, we excluded
genes that clustered under the general heading of “biological
processes” from further differential analysis. The remaining
list of genes was then subcategorized according to the
molecular/reaction pathways described by the Kyoto
Encyclopedia of Genes and Genomes (KEGG) using the
DAVID web tool and 0.1 EASE score threshold.
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Quantitative real time polymerase chain reaction: cDNA
from human retinas aged between 17 and 20 WG were used
for evaluative quantitative real-time polymerase chain
reaction (QRT–PCR) analyses. First-strand cDNA synthesis
was performed in a 20 μl reaction mixture using 1 μg RNA,
500 ng oligo (dT)18 primer, and 200 U SuperScript™ III
reverse transcriptase (Invitrogen). Amplification of Eph-A6
and ephrin A1–5 was measured using SYBR® GreenER™
(Invitrogen). All other genes were amplified using
commercially available TaqMan® probes (Applied
Biosystems, Melbourne, Australia). Primers were designed
within the coding domain sequence and across an intron using
reference sequences (RefSeq) derived from the NCBI Entrez
Gene database and the OligoPerfect™ Designer web-based
program (Invitrogen). Primer sequences and TaqMan probe
IDs are provided in Table 1 and Table 2, respectively.
Fluorescence was measured on a FAM 510 nm detection
channel using a commercial device (Rotor-Gene RG-3000;
Corbett Research, Sydney, Australia) and normalized relative
to a glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
reference gene. TaqMan amplification was performed in
duplicate, and SYBR GreenER PCR runs in triplicate, using
cDNA from three different specimens (total of 6 and 9
reactions per gene, respectively). Amplification specificity
TABLE 1. QRT–PCR PRIMERS
NCBI RefSeq                     Gene Forward primer (5′-3′) Reverse primer (5′-3′)
NM_001080448 Eph-A6 TTTTTCTCCCAAGCCATTCA ATGCCCAGTCCTTCCTTACC
NM_004428 ephrin-A1 GGTGACTGTCAGTGGCAAAA GCACTGTGACCGATGCTATG
NM_001405 ephrin-A2 GCCTGCGACTGAAGGTGTA CGGGCTGCTACACGAGTTAT
NM_004952 ephrin-A3 ACTCTCCCCCAGTTCACCAT GTCCCGCTGATGCTCTTCT
NM_005227 ephrin-A4 ACTACATCTCGGTGCCCACT CTGATGTGCCACTCTCTCCA
NM_001962 ephrin-A5 TTCATGATCGTGTTTTCGATG GCTGGGTATCCTTGGTGTTT
NM_002046 GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG
QRT–PCR primers were designed to verify gene expression of Eph-A6 and its ligands ephrin-A1 and -A4 , as well as ephrin-A2,
- A3,  and -A5 . These genes were amplified using a SYBR GreenER QRT–PCR kit (Invitrogen) and amplification was
normalized relative to a GAPDH  reference gene. QRT–PCR reactions were done in triplicate and repeated using cDNA from
three different specimens.
TABLE 2. TAQMAN PROBES
Entrez Gene ID Gene TaqMan probe ID Amplicon length
Axon guidance genes
22854 NTNG1 Hs01552822_m1 61
8829 NRP1 Hs00826129_m1 97
91584 PLXNA4 Hs00326001_m1 89
10154 PLXNC1 Hs00194968_m1 72
223117 SEMA3D Hs00380877_m1 97
56920 SEMA3G Hs00928864_m1 106
10505 SEMA4F Hs00188642_m1 64
137970 UNC5D Hs00369888_m1 83
Regulators of Angiogenesis
4879 NPPB Hs00173590_m1 82
5176 PEDF Hs01106937_m1 84
7422 VEGFA Hs00900057_m1 81
Other
2247 FGF2 Hs00266645_m1 82
2264 FGFR4 Hs00242558_m1 74
Control
2597 GAPDH Hs99999905_m1 122
QRT–PCR amplification of genes not listed in Table 1 was performed using TaqMan probes (Applied Biosystems) and
normalized relative to a GAPDH  reference gene. GAPDH  gene expression was also measured using a TaqMan probe.
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was assessed using either melt curve analysis (SYBR
GreenER) or gel electrophoresis (TaqMan). The results were
analyzed using the relative quantification method developed
by Pfaffl [31].
Macaque retinas and in situ hybridization: For localization
studies we used histological sections of retinas from eight
macaques of known gestational ages: fetal day (Fd) 80, Fd
115, and Fd 150. The sections were obtained by Prof. A.E.
Hendrickson from the breeding colony of the Primate Center
at Bogor Agricultural University, Indonesia, using protocols
approved by the University of Washington (Seattle, WA)
Animal Care Committee and in compliance with guidelines
of the Association for Research in Vision and Ophthalmology.
Fetuses were delivered by aseptic caesarean section,
euthanized by intraperitoneal overdose of barbiturate, and
then enucleated. Eyes were immediately injected with methyl
Carnoy’s fixative (methyl alcohol: acetic acid: chloroform,
6:3:1), then fixed whole by immersion for 1–2 h, as described
previously [32]. Sections were paraffin-embedded then cut at
8 μm. Only sections passing through the optic disc and foveal
region were used for quantitative analysis in this study.
Eph-A6 and PEDF were cloned from PCR products using
total RNA of human fetal retinas, the pGEM®-T DNA vector
system and JM109 competent cells (#A3600; Promega,
Madison, WI). A DIG RNA Labeling Kit SP6/T7 (#1175025;
Roche, Basel, Switzerland) was used to transcribe linearized
plasmid and generate DIG-labeled antisense and sense probes.
The Eph-A6 and PEDF riboprobes were hybridized overnight
at 55 °C and 58 °C, respectively, and then washed in saline
sodium citrate (pH 7.4) at 65 °C and 58 °C, respectively.
Paraffin sections of fetal macaque retina were processed as
described previously [16].
RESULTS
The RNA extracted from human fetal retinas and hybridized
to the arrays was of high quality and purity (Table 3).
Microarray quality controls were within manufacturer
recommendations, and control values were comparable
between arrays (Table 3). In addition, on all arrays the average
signal values of the poly(A) RNA and hybridization controls
increased relative to the order of spike concentrations (lys,
phe, thr, dap and bioB, bioC, bioD, cre, respectively)
indicating efficient labeling and hybridization of all samples.
The full set of microarray data has been deposited with the
NCBI Gene Expression Omnibus repository under accession
number GSE12621.
We generated two lists of differentially expressed genes:
macula versus surround; and macula versus nasal. We selected
a p-value cut-off of <0.01 which gave a false discovery rate
(step up method) of 14%. Using DAVID, we found the
differentially expressed genes were clustered according to
their functional roles, or biological process, generating over
200 gene ontology clusters. Small clusters were consolidated
under their parent categories to generate a simplified list
TABLE 3. RNA INTEGRITY AND MICROARRAY QUALITY CONTROLS
RNA integrity                                                  Microarray quality controls
Tissue (specimen) RIN# 260/280
Average
background Noise (Raw Q)
GAPDH 3′/5′
ratio % present calls
Macula (1) 8.9 2.03 89.8 3.6 1.09 51.4
Nasal (1) 9 2.03 89.3 3.55 1.15 50.8
Surround (1) 9.3 2 88.4 3.54 1.1 51.5
Macula (2) 9.5 2.04 90.8 3.6 1.09 50.1
Nasal (2) 9.9 1.96 82.8 3.32 1.12 50.9
Surround (2) 9.2 2.08 91.8 3.62 1.14 50.6
Macula (3) 9.1 1.97 80 3.05 1.21 51.9
Nasal (3) 9 1.97 73.4 2.83 1.16 55.5
Surround (3) 8.7 2.02 59.7 2.43 1.05 54.2
Macula (4) 9 1.85 53.9 2.19 1.13 54.6
Nasal (4) 9.3 1.97 57.5 2.37 1.14 54.9
Surround (4) 8.8 2.06 64.9 2.59 1.15 55.7
Integrity measures of RNA samples showed the samples were of appropriate purity for hybridization to microarrays. The RIN
was high, ranging from 8.4 to 9.9, and the 260/280 ratios were also high, ranging from 1.85 to 2.08. Microarray quality controls
were within manufacturer recommendations and control values were comparable between arrays. The sharp (hash mark)
indicates that the RNA integrity number (RIN) ranges from 1 to 10, with 10 indicating no RNA degradation, relative to a database
of approximately 1,300 total RNA samples of varying levels of integrity and derived from various tissues from human, rat and
mouse [23].
Molecular Vision 2009; 15:45-59 <http://www.molvis.org/molvis/v15/a5> © 2009 Molecular Vision
49
(Table 4) that shows the 15 most highly represented biological
processes in the microarray data sets. The largest cluster
identified includes genes involved with cell metabolism
(macula compared to surround: 1,520 genes; macula
compared to nasal: 1,059 genes). Differential expression of
genes in this cluster, including for example medium- and long-
wavelength sensitive cone opsins, glucose phosphate
dehydrogenase, and retinol dehydrogenase, is most likely due
to the fact that cells in the macula exit the cell cycle and
become mature neurons ahead of the rest of the retina. Other
categories in which differential gene regulation was expected
(because of the more highly differentiated state of macula
versus non-macular neurons at 19–20 WG) and confirmed,
include neurotransmitter transport (GO:0015813, GO:
0006836), secretion (GO:0007269), and signaling (GO:
0007215); cell cycle (GO:0007049), cell proliferation (GO:
0008283), and division (GO:0051301); and response to light
stimulus (GO:0009416).
In our further analyses we restricted the categories of
gene ontology terms to exclude differentially regulated genes
associated with the precocious development of the macula. Of
the genes reported in Table 4, 52% of the “macula compared
to surround” list of differentially expressed probe sets, and
43% of the “macula compared to nasal” list were thus
eliminated, leaving a total of 1,788 differentially expressed
genes in the “macula versus surround” list and 2,038 in the
and “macula versus nasal” list. Further clustering of the
restricted lists revealed genes that clustered into five common
and highly represented KEGG pathways between the two
lists: axon guidance (hsa04360), regulation of actin
cytoskeleton (hsa04810), extracellular matrix-receptor
interaction (hsa04512), focal adhesion (hsa04510), and ABC
transporters-general (hsa02010). The axon guidance KEGG
pathway was the most highly represented in the “macula cf
surround” list. Table 5 lists 25 genes with previously
identified roles in axon guidance common to both lists. Seven
of the 35 probe sets listed interrogate members of the
semaphorin/plexin/neuropilin gene family and six interrogate
members of the Eph/ephrin gene family.
To identify levels of expression of genes involved in the
regulation of angiogenesis, we assembled the gene expression
data for the 17 negative regulators of angiogenesis identified
in the Gene Ontology Consortium, and for isoforms of the
major retinal angiogenic factor, VEGF (Appendix 1). There
was no significant differential regulation of any of the
isoforms of VEGF detectable by the microarrays (Appendix
1). Of 17 negative regulators of angiogenesis, three—PEDF,
natriuretic peptide precursor B (NPPB), and collagen type
IVα2—showed statistically significant fold-changes (p<0.01)
in one or both sets of data (Table 6).
To test the veracity of the microarray data, we evaluated
the expression of eleven genes from Table 5 and Table 6 and
five additional genes of interest (including binding partners of
significantly regulated genes, closely related genes, and
TABLE 4. HIGHLY REPRESENTED CLUSTERS OF GENES IN THE DIFFERENTIAL EXPRESSION DATA
Gene Ontology ID Biological Process
Number of genes
  Macula
   versus
 surround
Macula
 versus
  nasal
GO:0008152 metabolism 1,520 1,059
GO:0065007 biological regulation 935 883
GO:0010467 gene expression 661 253
GO:0016043 cellular component organization and biogenesis 569 537
GO:0051179 localization 370 532
GO:0007154 cell communication 368 669
n/a# cell proliferation and division 358 355
GO:0032502 development 334 612
GO:0007155 cell adhesion 162 176
GO:0003008 system process 147 170
GO:0050896 response to stimulus 126 136
GO:0046903 secretion 81 64
GO:0040007 growth 64 66
GO:0050953 sensory perception of light stimulus 51 51
GO:0007059 chromosome segregation 30 33
The high representation of genes related to biological processes such as “metabolism” likely reflects the more advanced state
of macular development relative to non-macular retina. The sharp (hash mark) indicates that this term is a combination of cell
cycle (GO:0007049 ), cell proliferation (GO:0008283 ) and cell division (GO:0051301); Abbreviation: Gene Ontology (GO).
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significant angiogenic factors) using cDNA from retinas aged
between 17 and 20 WG by QRT–PCR. Figure 2 shows the
mean relative level of expression±standard error determined
by QRT–PCR (red columns) compared with differential
expression data from the microarray data (blue columns). The
results show strong consensus between the microarray and
QRT–PCR data for virtually all genes. The graphs confirm
downregulation of neuropilin 1 (NRP1) and plexin C1
(PLXNC1) in the macula, and upregulation of the other
selected genes in the macula. Comparison of fold-changes in
“macula compared to surround” and “macula compared to
nasal” (Figure 2A,B) revealed no significant difference
between the two data sets. In subsequent QRT–PCR
experiments we compared expression of ephrin A1-A5 and
Eph-A6 (Figure 2C), and four regulators of angiogenesis
(Figure 2D) in cDNA from macula and nasal locations. The
results indicated strong upregulation of Eph-A6 in the macula,
and downregulation of its 2 ligands, ephrin-A1 and -A4, as
well as ephrin-A2 and -A3. Ephrin-A5 did not amplify reliably
(data not shown). We found no differential regulation of
VEGFA by QRT–PCR, consistent with the microarray data.
We detected evidence of borderline downregulation of
fibroblast growth factor 2 (FGF2) in the macula, consistent
with a prior report [32]. Significantly, QRT–PCR confirmed
strong upregulation of two negative regulators of
angiogenesis: NPPB [33] and PEDF [34] (Figure 2D).
We selected one axon guidance gene, Eph-A6, and one
negative regulator of angiogenesis, PEDF, to examine their
retinal distributions by in situ hybridization. Figure 3A shows
a macaque retina at Fd 115, equivalent to around 25 WG in
TABLE 5. DIFFERENTIALLY REGULATED AXON GUIDANCE GENES, P<0.01
Gene title Gene symbol
DE# (%)
Macula
versus
surround
DE# (%)
Macula
versus 
nasal
Affymetrix
Probe Set ID
actin binding LIM protein 1 ABLIM1 33.12 19.67 200965_s_at
Rho guanine nucleotide exchange factor (GEF) 12 ARHGEF12 20.26 27.86 201334_s_at
cell division cycle 42 (GTP binding protein, 25 kDa) CDC42 47.89 60.9 214230_at
calcium binding protein P22 CHP 34.91 23.52 214665_s_at
chemokine (C-X-C motif) receptor 4 CXCR4 −48.13 −49.1 209201_x_at
chemokine (C-X-C motif) receptor 4 CXCR4 −51.04 −53.58 211919_s_at
chemokine (C-X-C motif) receptor 4 CXCR4 −45.38 −49.6 217028_at
ephrin-A4 EFNA4 −32.41 −42.61 205107_s_at
Eph receptor A6 EPHA6 14.76 19.94 1561396_at
Eph receptor B1 EPHB1 62.04 63.27 210753_s_at
Eph receptor B1 EPHB1 53.66 57.47 211898_s_at
Eph receptor B1 EPHB1 65.06 69.8 230425_at
Eph receptor B2 EPHB2 −34.75 −45.42 210651_s_at
FYN oncogene related to SRC, FGR, YES FYN 17.01 16.65 216033_s_at
guanine nucleotide binding protein (G protein), alpha inhibiting activity
polypeptide 3 GNAI3 −26.52 −18.49 201179_s_at
integrin, beta 1 ITGB1 −32.93 −36.94 1553678_a_at
integrin, beta 1 ITGB1 −27.88 −31.33 211945_s_at
NCK adaptor protein 1 NCK1 −26.42 −17.45 204725_s_at
neuropilin 1 NRP1 −39.47 −49.84 212298_at
netrin G1 NTNG1 92.48 272 236088_at
p21 protein (Cdc42/Rac)-activated kinase 3 PAK3 38.02 40.06 214607_at
p21 protein (Cdc42/Rac)-activated kinase 7 PAK7 40.33 45.9 213990_s_at
plexin C1 PLXNC1 −58.01 −60.43 206470_at
plexin C1 PLXNC1 −74.36 −67.57 206471_s_at
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform PPP3CB 20.31 21.65 202432_at
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform PPP3CC 32.46 48.15 207000_s_at
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform PPP3CC 35.88 42.04 32541_at
semaphorin 3D SEMA3D 66.94 44.71 215643_at
semaphorin 4F SEMA4F 39 46.44 210124_x_at
semaphorin 4F SEMA4F 14.5 12.59 211157_at
semaphorin 4F SEMA4F 44.54 39.42 228660_x_at
slit homolog 2 (Drosophila) SLIT2 52.22 67.76 209897_s_at
slit homolog 2 (Drosophila) SLIT2 57.58 65.8 228850_s_at
SLIT-ROBO Rho GTPase activating protein 2 SRGAP2 52 37.55 213329_at
unc-5 homolog D (C. elegans) UNC5D 166.4 191.62 231325_at
Genes associated with the precocious development of the macula were excluded from further analysis. In the adjusted microarray
data sets there was a high representation of genes associated with the axon guidance KEGG  pathway. Sharp (hash mark) indicates
that differential expression (DE) is the ratio of expression levels at the macula compared with nasal/surround, expressed here
as a % value. For example, 50% DE indicates a 1.5 fold upregulation, and −50% DE indicates a 1.5 fold down-regulation.
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the human, hybridized to show the retinal distribution of Eph-
A6 mRNA. In this retina, and others from macaques aged Fd
110 to postnatal 3 months (data not shown), Eph-A6 mRNA
expression was high in the macula, reaching a peak at the
developing fovea, and was lower in the periphery [35]. We
also detected a graded expression of Eph-A6 across the
thickness of the ganglion cell layer (GCL) that is high in the
inner GCL and low in the outer GCL at foveal and parafoveal
locations, but not peripheral locations (Figure 3). In situ
hybridization for PEDF in developing macaque retinas
(Figure 4A-D) shows PEDF mRNA in the GCL and RPE,
consistent with previous reports [36], although we found low
to very low PEDF expression in the developing
photoreceptors of fetal macaque retinas (Figure 4A-D). PEDF
mRNA expression was low in the RPE at Fd 80 (about 17 WG
in humans), but higher at Fd 150 (about 32 WG in humans;
Figure 4A,B compared to Figure 4C,D). We detected PEDF
expression at higher levels in the GCL of central retina,
compared with non-central retina, at both Fd 80 and Fd 150.
This gradient of expression of PEDF in the GCL is consistent
with the microarray and QRT–PCR data.
DISCUSSION
To our knowledge, this is the first investigation into the
differential gene expression in the developing macula.
Previous differential expression studies have used adult tissue
[37] or have not specifically investigated the developing
macula [38].
Differential expression of anti-angiogenic factors: This
is the first report of upregulation of anti-angiogenic factors in
the primate macula: the widely recognized inhibitor PEDF,
and a novel anti-angiogenic regulator for the retina, NPPB.
The apparent downregulation of collagen type IVα2 in the
macula is most likely due to the presence of collagen-invested
retinal vessels in the non-macular samples. Our findings are
consistent with a role for both PEDF and NPPB (also known
as brain natriuretic peptide) in the definition of the avascular
area in the central macula, which, at a later stage of
development, will include the fovea centralis.
PEDF is a neurotrophin [39] and has potent anti-
angiogenic effects in human [36] and other mammalian
retinas [40,41]. The anti-angiogenic effects of PEDF occur
through stimulation of the Fas/Fas ligand-mediated apoptotic
pathway which targets the endothelial cells of immature
vessels, and may also downregulate the caspase-8 inhibitor,
c-FLIP [42]. Both of these effects reduce the survival of new
endothelial cells, even in the presence of pro-angiogenic
factors. VEGF-induced angiogenesis can be directly inhibited
by PEDF via the intracellular proteolysis of VEGFR-1 or
inhibition of its phosphorylation [43].
Less is known about NPPB in the retina. NPPB is a
cardiac hormone and influences several systemic functions
such as body fluid homeostasis, blood pressure, cardiac
function, bone growth, and vascular tone [44]. NPPB has been
amplified from adult human retina [33] and the protein
localized to ganglion, Müller [33,45], and amacrine cells
[46] in humans and rats. Natriuretic peptides can affect
VEGF-induced angiogenesis by inhibiting certain signaling
molecules such as ERK, JNK, and p38 members of the MAP
kinase family through stimulation of a cyclic GMP signaling
cascade (natriuretic peptide receptors NPR-A and -B) or
through a less well understood mechanism involving NPR-C
[44,47-49].
Type IV collagen is an important structural component
of basement membrane and is required for blood vessel
formation [50]. The 24 kDa C-terminal domain of α2 chains
of type IV collagen, also known as canstatin, inhibits
endothelial cell proliferation and migration, and induces other
anti-angiogenic mechanisms including Fas ligand expression
(reviewed in [51]). One would expect type IV collagen to be
restricted to the more mature retinal vessels, which at 19–
20 WG, are mainly in nasal and temporal superior/inferior
retina; very few vessels would have been biopsied in our
macular samples.
TABLE 6. LEVELS OF EXPRESSION OF ANTI-ANGIOGENIC GENES IN DEVELOPING HUMAN RETINA, P<0.01
Gene title                                               Gene symbol
   Macula versus surround     Macula versus nasal
Affymetrix
     Probe
     Set IDp= DE# (%) p=             DE# (%)
pigment epithelium derived factor (serpin
peptidase inhibitor, clade F member 1)
PEDF 0.003 49.52 0.004 46.62 202283_at
natriuretic peptide precursor B NPPB 0.003 28.57 0.002 33.05 206801_at
collagen, type IV, alpha 2 COL4A2 0.151 −21.16* 0.005 −59.72 211964_at
collagen, type IV, alpha 2 COL4A2 0.033 −35.56* 0.001 −85.44 211966_at
PEDF, NPPB, and COL4A2 were the only anti-angiogenic genes, out of 17 known negative angiogenic regulators, to show
significant differential expression between the macula and surrounding retina. Non-significant fold changes (*p>0.01) are
indicated.
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Differential expression of guidance factors: We have also
identified 25 axon guidance genes differentially expressed in
the macula, including 12 members of the ephrin, semaphorin,
slit and netrin families, which are also regulators of vascular
development [52]. Significantly, we detect this differential
regulation of guidance genes at the macula 8–12 weeks after
macular ganglion cells differentiate and send out axons, and
3–4 weeks after the majority of retinal axons have exited the
retina [30]. Retinal neurons are generated in a stereotyped
sequence [53] and along a centro-peripheral gradient [30,54],
Figure 2. Measures of differential gene expression. Microarray data are indicated by blue bars and QRT–PCR data by red bars. We selected
differentially regulated genes (*p<0.01) identified by the microarray, binding partners of those differentially regulated genes, as well as five
other relevant genes of interest: SEMA3G, FGF2, VEGF, and ephrin-A2 and -A3. A, B: Selected axonal guidance genes. These genes were
significantly upregulated or downregulated in the macula compared to either the nasal (A) or surround (B) samples, with the exception of
SEMA3G, which was significantly upregulated only in the macula versus surround comparison (B). C: QRT–PCR indicates strong differential
regulation of Eph-A6 and its ligands ephrin-A1 and -A4 in the macula compared with nasal samples. The QRT–PCR results showed stronger
trends in differential expression compared to the microarray, with the exception of ephrin-A3, which QRT–PCR suggests is not differentially
expressed. Similar data were obtained from macula versus surround comparisons. D: The QRT–PCR confirmed significant upregulation of
PEDF and NPPB in the macula compared with the nasal sample. Both the microarray and QRT–PCR findings indicate no differential regulation
of VEGFA, the major isoform expressed in the retina. The small downregulation of FGF2 in the microarray and QRT–PCR data are consistent
with our previous findings that show a downregulation of FGF2 in macular cones, but not in other layers of the retina, by in situ hybridization
[32]. Note that the standard error of the microarray fold changes is derived from the distribution of fold changes measured across the four
specimens. Abbreviations: fibroblast growth factor 2 (FGF2); natriuretic peptide precursor B (NPPB); neuropilin 1 (NRP1); netrin G1
(NTNG1); pigment epithelium derived factor (PEDF); plexin C1 (PLXNC1); semaphorin 3D (SEMA3D); semaphorin 3G (SEMA3G);
semaphorin 4F (SEMA4F); unc-5 homolog D (C. elegans; UNC5D); vascular endothelial growth factor A (VEGFA).
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such that ganglion cells and cones of the incipient fovea are
among the first neurons generated in the primate retina.
Ganglion cell axons are observed in the optic stalk from
around 8 WG in humans [55] (reviewed in [56]), reach a peak
number at 16–17 WG, and stabilize at adult values between
25 and 30 WG, approximately [57]. Although for the most
part, axon guidance within the retina and visual targets has not
been studied in primate retina (see, however, Lambot et al.,
[58]), we know from studies of other species that a range of
axon guidance factors are expressed in the retina during the
period of axon outgrowth, to guide axons to the optic disc
[59,60], and regulate targeting of their axon terminals by
interaction with their binding partners in the primary visual
nuclei [61-65]. Because axons of macular ganglion cells are
among the first to enter the optic nerve—estimated between
8 and 14 WG—we interpret the sustained expression of
guidance factors in the macula at 19–20 WG, as detected in
the present study, to be primarily related to vascular
patterning, rather than axon guidance.
Many genes originally identified by their involvement in
axon patterning are also implicated in vascular patterning. The
semaphorin-plexin family of genes share with VEGFA the
capacity to bind neuropilin 1, expressed by both blood vessels
and axons. Class 3 semaphorins are also known to have a
repellent effect during vascular morphogenesis via
interactions with integrins [66]. Eph receptors and their ephrin
ligands have key roles in axon guidance, provide guidance
cues for endothelial cells during development, are involved in
assembly and maintenance of vascular networks, and
arteriovenous differentiation [67]. Netrin is a potent vascular
mitogen [22] and has a role in repelling developing vessels
via interactions with the UNC5 receptor [68], while Slit2 is
implicated in endothelial cell migration [52]. Of particular
interest are the repellent effects of netrin-UNC5 interactions
[68] and Eph-ephrin signaling [69] on developing vessels as
well as axons during development. We propose that a graded
expression of genes involved in repellent signaling that is
centered on the fovea during development - similar to the one
we report here for Eph-A6 (Figure 3) - retards the growth of
vessels into the central region of the retina, and contributes to
definition of the foveal avascular area (in preparation).
Significance: The spatial resolving power of the fovea is
directly attributable to cone inner segment spacing which
reaches a peak of 100,000 to 300,000 mm−2 [70] at the
geometric center of the avascular area, and corresponds with
the central fovea (foveola) in adult retinas. Studies using
adaptive optics show that while most individuals do not use
the area of peak cone density for fixation, the mean
displacement of the fixation point from the peak cone density
(50 µm) [71] places it comfortably within the average-sized
avascular area (500–700 µm). Shadowing of the
photoreceptor mosaic causes angioscotomas in the visual
Figure 3. In situ hybridization for Eph-A6 mRNA in fetal macaque retina. Small arrows indicate the profiles of retinal vessels, and the thicker
arrows (to the left) mark the vessels on the margin of the foveal avascular zone (FAZ). Double-headed arrows show optical densitometry
transects (B-D). A: Eph-A6 mRNA expression is shown in a section through the developing fovea in a retina from a macaque at Fd 115. There
are high levels of Eph-A6 expression (dark reaction product) in the inner part of the ganglion cell layer (GCL) at the developing fovea and
lower levels of Eph-A6 expression in the GCL at progressively more peripheral locations, consistent with both the QRT–PCR and microarray
findings. A second gradient of Eph-A6 mRNA expression across the depth of the GCL at foveal and parafoveal locations (left and central of
A) was also detected, as shown by optical densitometry profiles at B, C, and D. B: A transect through the retina within the FAZ shows peak
expression of Eph-A6 mRNA in the inner GCL, declining to low levels in the outer GCL. C: A weaker gradient was detected across the GCL
about 1.5 mm from the incipient fovea, with peak levels approximately 70% of the peak value in the fovea. D: Eph-A6 expression was generally
lower in the periphery, although slightly higher levels are present in the GCL compared with the other layers. Values in C and D are normalized
to the peak intensity in B. Abbreviations: arbitrary units (AU); inner nuclear layer (INL); outer nuclear layer (ONL).
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cortex [72]. Thus, reduction in the diameter of macular
vessels, and an absence of vessels overlying the region of peak
cone density at the fovea, might be regarded as an adaptive
advantage that favors optimal spatial acuity. It is possible that
the mechanisms that mediate specialization of the macular
vessels, and which define the foveal avascular area,
“piggyback” on axon guidance mechanisms in effect earlier
in development. One hypothesis is that the guidance factors
that repel ganglion cell axons away from central retina into
the arcuate axon bundles and optic nerve head also guide
Figure 4. In situ hybridization for PEDF mRNA (dark reaction product) in fetal macaque retina. Layers of the retina are indicated by the
vertical brackets. Vessel profiles are indicated in C and D by oblique arrows. A, B: At Fd 80, higher levels of PEDF expression were detected
in the GCL at the incipient fovea (A) compared with a location near the optic disc (B). PEDF levels were low in the RPE at Fd 80. Labeled
cells in the IPL of A are most likely displaced ganglion cells which are common in central retina at this age. C, D: In the Fd 150 fovea (C),
relatively high levels of PEDF mRNA are present in the GCL compared with levels in the GCL near the optic disc (D). Inset shows increased
PEDF expression in the RPE at Fd 150 compared with Fd 80 (see A and B). Abbreviations: ganglion cell layer (GCL); inner nuclear layer
(INL); inner plexiform layer (IPL); outer nuclear layer (ONL); outer plexiform layer (OPL); nerve fiber layer (NFL); retinal pigmented
epithelium (RPE).
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vessels out of the optic nerve head and repel them from the
foveal region, at a slightly later phase of development.
A series of findings suggest that definition of an avascular
area within the macula is required for subsequent formation
of a fovea. First, developmental studies indicate that in
macaques and marmosets the foveal avascular area is defined
before the fovea begins to form [18,20]. Second, optical
coherence tomography in humans indicates that absence of an
avascular area is associated with foveal hypoplasia, or absence
of a foveal depression [14,15]. Third, finite element analysis
predicts that differential elasticity in the foveal region,
resulting from a local absence of retinal vessels, is sufficient
to promote development of the foveal depression due to
growth-induced stretch [73]. Our present results suggest that
both anti-angiogenic and axon guidance factors have key roles
in regulating vascular growth in the macula and in specifying
the foveal region as a vascular “no go” area, and are thus
indirectly implicated in the later formation of the fovea
centralis.
Expression of anti-angiogenic factors in the macula
during development, and guidance factors that have roles in
regulating vascular growth in the macula through repellent
mechanisms, suggests there may be a biological conflict of
interest in the primate macula; between high density neural
networks, with correspondingly high levels of energy
demands, on the one hand, and adaptive pressure to constrain
blood vessel growth to avoid shadowing of photoreceptors, on
the other. These findings may be useful to understand the
vulnerability of the macula to degeneration and to develop
new therapeutic strategies to inhibit neovascularization.
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Appendix 1. Levels of expression of angiogenic and anti-angiogenic genes
in developing human retina
Differential expression data of the 17 negative regulators
of angiogenesis identified in the Gene Ontology Consortium,
and the isoforms of VEGF. To access the data, click or select
the words “Appendix 1.” This will initiate the download of a
compressed (pdf) archive that contains the file.
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